ArticleCancer communications (London, England)2022

ABTL0812 enhances antitumor effect of paclitaxel and reverts chemoresistance in triple-negative breast cancer models.

Emma Polonio-Alcalá et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.